MCTA vs AEYE

For growth investors, AudioEye, Inc.

(AEYE) is the stronger pick with 14. 5% revenue growth year-over-year, versus 3. 4% for Charming Medical Limited Class A Ordinary Shares (MCTA). Charming Medical Limited Class A Ordinary Shares (MCTA) offers the better valuation at 414. 5x trailing P/E, making it the more compelling value choice. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

Over the past 5 years, Charming Medical Limited Class A Ordinary Shares (MCTA) delivered a total return of +319.

3%, compared to -60. 2% for AudioEye, Inc. (AEYE). Over 10 years, the gap is even starker: MCTA returned +319. 3% versus AEYE's +102. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

On balance sheet safety, AudioEye, Inc.

(AEYE) carries a lower debt/equity ratio of 15% versus 24% for Charming Medical Limited Class A Ordinary Shares — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), AudioEye, Inc.

(AEYE) is pulling ahead at 14. 5% versus 3. 4% for Charming Medical Limited Class A Ordinary Shares (MCTA). On earnings-per-share growth, the picture is similar: Charming Medical Limited Class A Ordinary Shares grew EPS 54. 2% year-over-year, compared to 30. 6% for AudioEye, Inc.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Charming Medical Limited Class A Ordinary Shares (MCTA) is the more profitable company, earning 19.

3% net margin versus -7. 6% for AudioEye, Inc. — meaning it keeps 19. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: MCTA leads at 22. 3% versus -7. 9% for AEYE. At the gross margin level — before operating expenses — AEYE leads at 78. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

For long-horizon retirement investors, Charming Medical Limited Class A Ordinary Shares (MCTA) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (+319.

3% 10Y return). AudioEye, Inc. (AEYE) carries a higher beta of 2. 29 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (MCTA: +319. 3%, AEYE: +102. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (MCTA (Healthcare) and AEYE (Technology)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.